Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
- PMID: 31283441
- PMCID: PMC7123914
- DOI: 10.1146/annurev-virology-092818-015530
Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?
Abstract
The recent market approvals of recombinant adeno-associated virus (rAAV) gene therapies in Europe and the United States are landmark achievements in the history of modern science. These approvals are also anticipated to herald the emergence of a new class of therapies for monogenic disorders, which had hitherto been considered untreatable. These events can be viewed as stemming from the convergence of several important historical trends: the study of basic virology, the development of genomic technologies, the imperative for translational impact of National Institutes of Health-funded research, and the development of economic models for commercialization of rare disease therapies. In this review, these historical trends are described and the key developments that have enabled clinical rAAV gene therapies are discussed, along with an overview of the current state of the field and future directions.
Keywords: AAV; adeno-associated virus; clinical trial; gene therapy; genetic disease; genome editing.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7123914/bin/nihms-1566678-f0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7123914/bin/nihms-1566678-f0002.gif)
Similar articles
-
The Perspective of DMPK on Recombinant Adeno-Associated Virus-Based Gene Therapy: Past Learning, Current Support, and Future Contribution.AAPS J. 2022 Jan 31;24(1):31. doi: 10.1208/s12248-021-00678-7. AAPS J. 2022. PMID: 35102450 Free PMC article. Review.
-
Evolving AAV-delivered therapeutics towards ultimate cures.J Mol Med (Berl). 2021 May;99(5):593-617. doi: 10.1007/s00109-020-02034-2. Epub 2021 Feb 16. J Mol Med (Berl). 2021. PMID: 33594520 Free PMC article. Review.
-
My Pathway to Adeno-Associated Virus and Adeno-Associated Virus Gene Therapy: A Personal Perspective.Hum Gene Ther. 2020 May;31(9-10):494-498. doi: 10.1089/hum.2020.29120.bca. Epub 2020 Apr 9. Hum Gene Ther. 2020. PMID: 32275185 Free PMC article. No abstract available.
-
Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspective.Hum Gene Ther. 2015 May;26(5):257-65. doi: 10.1089/hum.2015.025. Epub 2015 Apr 20. Hum Gene Ther. 2015. PMID: 25807962 Free PMC article. Review.
-
Birth of a new therapeutic platform: 47 years of adeno-associated virus biology from virus discovery to licensed gene therapy.Mol Ther. 2013 Nov;21(11):1976-81. doi: 10.1038/mt.2013.226. Mol Ther. 2013. PMID: 24201212 Free PMC article. No abstract available.
Cited by
-
An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species.Nat Commun. 2024 May 6;15(1):3780. doi: 10.1038/s41467-024-48221-4. Nat Commun. 2024. PMID: 38710714 Free PMC article.
-
Analysis of the impact of pluronic acid on the thermal stability and infectivity of AAV6.2FF.BMC Biotechnol. 2024 Apr 25;24(1):22. doi: 10.1186/s12896-024-00853-6. BMC Biotechnol. 2024. PMID: 38664752 Free PMC article.
-
Adeno-associated virus as a delivery vector for gene therapy of human diseases.Signal Transduct Target Ther. 2024 Apr 3;9(1):78. doi: 10.1038/s41392-024-01780-w. Signal Transduct Target Ther. 2024. PMID: 38565561 Free PMC article. Review.
-
Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis.Cancer Gene Ther. 2024 May;31(5):766-777. doi: 10.1038/s41417-024-00751-1. Epub 2024 Mar 13. Cancer Gene Ther. 2024. PMID: 38480976
-
Peptide Self-Assembly Facilitating DNA Transfection and the Application in Inhibiting Cancer Cells.Molecules. 2024 Feb 21;29(5):932. doi: 10.3390/molecules29050932. Molecules. 2024. PMID: 38474444 Free PMC article.
References
-
- Atchison RW, Casto BC, Hammon WM. 1966. Electron microscopy of adenovirus-associated virus (AAV) in cell cultures. Virology 29:353–57 - PubMed
-
- Blacklow NR, Hoggan MD, Kapikian AZ, Austin JB, Rowe WP. 1968. Epidemiology of adenovirus-associated virus infection in a nursery population. Am. J. Epidemiol 88:368–78 - PubMed
-
- Blacklow NR, Hoggan MD, Sereno MS, Brandt CD, Kim HW, et al. 1971. A seroepidemiologic study of adenovirus-associated virus infection in infants and children. Am. J. Epidemiol 94:359–66 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical